Advanced Biomed Inc. successfully regained compliance with Nasdaq's minimum bid price requirement after a reverse stock split on February 20, 2026, and will remain listed on Nasdaq. The decision was communicated to the company on March 12, 2026, following a hearing held on February 17, 2026.